GIANNINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.186
EU - Europa 5.324
AS - Asia 3.501
SA - Sud America 350
AF - Africa 98
OC - Oceania 79
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.543
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.069
RU - Federazione Russa 2.042
SG - Singapore 1.017
IT - Italia 954
HK - Hong Kong 716
CN - Cina 685
IE - Irlanda 527
SE - Svezia 451
PL - Polonia 422
VN - Vietnam 352
BR - Brasile 283
KR - Corea 278
DE - Germania 196
UA - Ucraina 187
FI - Finlandia 174
FR - Francia 158
GB - Regno Unito 110
TR - Turchia 107
IN - India 104
JP - Giappone 90
AU - Australia 77
CA - Canada 68
CI - Costa d'Avorio 42
BD - Bangladesh 32
AR - Argentina 27
NL - Olanda 21
MX - Messico 18
BE - Belgio 17
IQ - Iraq 17
CH - Svizzera 12
JO - Giordania 12
AE - Emirati Arabi Uniti 11
ES - Italia 11
ID - Indonesia 11
NG - Nigeria 11
PK - Pakistan 11
ZA - Sudafrica 11
CO - Colombia 10
EC - Ecuador 9
UZ - Uzbekistan 8
AZ - Azerbaigian 7
JM - Giamaica 7
MA - Marocco 7
SA - Arabia Saudita 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
KE - Kenya 6
LT - Lituania 6
MY - Malesia 6
RO - Romania 6
CL - Cile 5
EG - Egitto 5
PH - Filippine 5
SC - Seychelles 5
DZ - Algeria 4
EU - Europa 4
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PR - Porto Rico 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UY - Uruguay 3
BO - Bolivia 2
GD - Grenada 2
GR - Grecia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VG - Isole Vergini Britanniche 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 18.534
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.248
Ashburn 732
Singapore 700
Fairfield 674
Hong Kong 590
Chandler 542
Dublin 527
Warsaw 420
San Jose 419
Cambridge 311
Seattle 300
Woodbridge 289
Seoul 278
Jacksonville 265
Wilmington 256
Beijing 241
Houston 237
Milan 211
The Dalles 190
Buffalo 176
Ann Arbor 161
Princeton 136
Los Angeles 113
Lauterbourg 111
Boardman 106
Boston 100
Ho Chi Minh City 99
Izmir 93
Altamura 91
Tokyo 90
Hanoi 87
Rome 84
Lawrence 80
Melbourne 76
Mumbai 72
Medford 62
Dallas 53
Hefei 48
Bremen 43
Abidjan 42
Shanghai 42
San Diego 39
Munich 38
New York 36
Florence 35
Moscow 35
Falls Church 26
Naples 25
Norwalk 25
Helsinki 23
Paris 23
Toronto 23
Turin 23
São Paulo 22
Figino 21
Redondo Beach 21
Da Nang 19
Brussels 17
Washington 17
Andover 16
Bologna 16
Hillsboro 15
Orem 15
Turku 15
Brooklyn 14
Chicago 14
Dearborn 13
Frankfurt am Main 13
Palermo 13
Atlanta 12
London 12
Verona 12
Abuja 11
Auburn Hills 11
Bern 11
Kent 11
Venice 11
Haiphong 10
Modena 10
Baghdad 9
Denver 9
Guangzhou 9
Montreal 9
Porto Alegre 9
Miano 8
Old Bridge 8
Salerno 8
Stockholm 8
Tashkent 8
West Jordan 8
Brasília 7
Dhaka 7
Frankfurt Am Main 7
Genoa 7
Rio de Janeiro 7
Bari 6
Curitiba 6
Dong Ket 6
Hải Dương 6
Nha Trang 6
Totale 12.276
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 334
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 319
HCV and lymphoproliferation 280
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 259
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 221
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 216
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 209
Host genetic determinants in HCV-related mixed cryoglobulinemia 205
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 196
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 192
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment 192
Analysis of HCV persistence in patients with sustained virological response 190
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma 188
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 187
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 185
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 177
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 176
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 176
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 176
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 176
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 175
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia 175
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 174
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 172
Involvement of PI3K in HCV-related lymphoproliferative disorders 171
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 170
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 169
Host genetic determinants in HCV-related mixed cryoglobulinemia 169
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 168
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. 166
T(14;18) translocation in chronic hepatitis C virus infection 165
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 165
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 165
HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation 165
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 162
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 162
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 158
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 157
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 157
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 156
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector 156
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 151
Hepatitis C virus core protein enhances B lymphocyte proliferation 150
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 150
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 150
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 149
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 149
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 149
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 148
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 147
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA 144
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 144
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 143
Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis 142
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 141
HCV infection and carotid atherosclerosis: evidence in favour of a local viral action inside the plaque 141
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 141
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis 140
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 139
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 139
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 138
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 137
Hepatitis C virus lymphotropism and possible pathogenetic implications 136
The Hepatitis C Virus Infection as a Systemic Disease 136
Hepatitis C virus RNA localization in human carotid plaques. 136
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis? 135
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 135
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases 131
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 131
Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells. Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells 130
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 130
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 129
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 129
Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis 128
Hepatitis C virus-related lymphoproliferative disorders: an overview 127
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes 126
Hepatotropic viruses: new insights in pathogenesis and treatment 125
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 125
E' possibile la trasmissione del virus C dell'epatite nei centri di dialisi mediante il passaggio attraverso la membrana emodialitica? Risultati di uno studio preliminare 124
HCV infection in B-cell non-Hodgkin's lymphoma 124
Eventi Oncomolecolari nella Crioglobulinemia Mista 123
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 122
Is t(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 122
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 121
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 121
Hepatitis C virus lymphotrophism: lesson from a decade of studies 120
Hepatitis C virus biology. 120
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 120
HCV infection of mononuclear cells in chronic hepatitis and in mixed cryoglobulinaemia: possible pathogenetic implications. 120
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 118
Could HGV infection be implicated in lymphomagenesis? 116
HCV infection in B-cell non-Hodgkin's lymphoma 115
HCV infection in B-cell non-Hodgkin’s lymphoma. 114
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx 113
Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. 113
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 111
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? 110
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 109
Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues 109
Totale 15.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.319
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022879 6 122 21 43 29 18 24 54 35 12 198 317
2022/20232.211 224 230 99 184 230 459 325 103 244 22 59 32
2023/2024658 43 99 145 41 50 83 17 132 7 11 12 18
2024/20255.735 166 591 364 834 2.065 608 74 383 267 94 163 126
2025/20265.156 643 710 309 205 521 181 646 242 569 281 96 753
2026/2027118 118 0 0 0 0 0 0 0 0 0 0 0
Totale 18.556